Filing Details

Accession Number:
0001104659-24-030992
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:01:34
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 16:01:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1295947 Prestige Consumer Healthcare Inc. PBH Pharmaceutical Preparations (2834) 201297589
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1749505 Beth Mary Fritz 660 White Plains Road
Tarrytown NY 10591
Svp Quality & Regulatory No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2024-03-01 62 $57.18 15,996 No 4 M Direct
Common Stock, Par Value $0.01 Per Share Disposition 2024-03-01 62 $70.43 15,934 No 4 S Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2024-03-01 110 $30.56 16,044 No 4 M Direct
Common Stock, Par Value $0.01 Per Share Disposition 2024-03-01 110 $70.41 15,934 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2024-03-01 62 $0.00 62 $57.18
Common Stock Employee Stock Options (right to buy) Disposition 2024-03-01 110 $0.00 110 $30.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-05-09 No 4 M Direct
0 2029-05-06 No 4 M Direct
Footnotes
  1. Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $70.00 to $70.43.
  2. Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $70.00 to $70.41.
  3. The options vested in three installments on 1,817 shares on May 9, 2017 and 1,818 shares each on May 9, 2018 and May 9, 2019.
  4. The options vested in three installments on 2,540 shares on May 6, 2020 and 2,541shares each on May 6, 2021 and May 6, 2022